Amy Lightner named CMO of Direct Biologics

Privately-held Direct Biologics has named Amy Lightner its chief medical officer.

Direct Biologics is an Austin, Texas, USA-based late-stage biotechnology company leveraging its regenerative medicine platform using extracellular vesicles (EVs) derived from bone marrow mesenchymal stem cells (MSCs).

The company’s therapeutic product candidate, ExoFlo, was designed utilizing the firm’s EV platform technology to reduce inflammation, promote healing at the cellular level, and repair tissues by activating self-repair and regenerative pathways. It is being tested in a Phase III EXTINGuish trial in hospitalized adults with severe or critical COVID-19 induced acute respiratory distress syndrome.